您的位置：首页 > 产品中心 > PF-06260933 二盐酸盐
PF-06260933 二盐酸盐
PF-06260933 dihydrochloride
产品别名
PF-06260933 二盐酸盐
PF-06260933 dihydrochloride
5-(4-Chloro-phenyl)-[3,3′]bipyridinyl-6,6′-diamine dihydrochloride
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C16H13ClN4 · 2HCl |
| Molecular weight | 369.68 |
| PubChem Substance ID【PubChem化学物质编号】 | 329823806 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | PF-06260933 dihydrochloride is a MAP4K4 inhibitor. |
| Other Notes【其他说明】 | This compound was developed by Pfizer for Kinase Phosphatase Biology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
| Legal Information【法律信息】 | Sold for research purposes under agreement from Pfizer Inc. Pfizer is a registered trademark of Pfizer, Inc. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| manufacturer/tradename | Pfizer® |
| color【颜色】 | white to beige |
| solubility【溶解性】 | H2O: 20 mg/mL, clear |
| originator【创始人】 | Pfizer |
| storage temp.【储存温度】 | room temp |
| SMILES string | NC1=C(C2=CC=C(Cl)C=C2)C=C(C3=CN=C(N)C=C3)C=N1.[H]Cl |
| InChI | 1S/C16H13ClN4.ClH/c17-13-4-1-10(2-5-13)14-7-12(9-21-16(14)19)11-3-6-15(18)20-8-11;/h1-9H,(H2,18,20)(H2,19,21);1H |
| InChI key | ZKIFOIROEWYGKV-UHFFFAOYSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS06 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | P301 + P310 + P330 |
| Hazard Classifications【危险分类】 | Acute Tox. 3 Oral |
| Storage Class Code【储存分类代码】 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
| WGK | WGK 3 |
